MedTrace Logo

Pharmaceutical Intervention and Adherence to bDMARDs in Spondyloarthritis.

NCT04001673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-01-29

No results posted yet for this study

Summary

There is a lack of knowledge among patients concerning their treatment with bDMARDs, which could lead to low adherence.

The objective of this study is to assess the impact of a pharmacist's intervention on the adherence to bDMARDs in patients with Spondyloarthritis.

Conditions

  • Spondyloarthritis
  • Treatment Adherence

Interventions

BEHAVIORAL

Pharmacist's intervention

Information about bDMARDs management.

Sponsors & Collaborators

  • Dr Ornella Conort

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2018-09-15
Completion
2018-09-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04001673 on ClinicalTrials.gov